GlaxoSmithKline Pakistan products and prices in Pakistan
Manufacturer & importer Has products under both a manufacturing licence (DML) and a sale licence (DSL). Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Public pharmaceutical company - GSK group · Karachi · Pakistan
Pakistan operating company of the GSK group, supplying and supporting prescription medicines and healthcare products in the local market.
GlaxoSmithKline Pakistan products in Pakistan
GlaxoSmithKline Pakistan Limited has 104 medicine presentations registered in Pakistan under 36 brands, covering 34 generic medicines. Most of its products are in Anti-infectives, Dermatology and Vaccines & immunologicals. Its brands with the most registered strengths and packs are Augmentin (Amoxicillin + clavulanic acid), Amoxil (Amoxicillin), Bactroban (Mupirocin) and Betnovate (Betamethasone valerate, Betamethasone). 104 products have an official DRAP price on MedInfoBase. See all 36 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Public pharmaceutical company - GSK group
- Address
- 35 Dockyard Road, West Wharf, Karachi 74000, Pakistan · 74000
- Website
- pk.gsk.com ↗
- Phone
- +92 21 111 475 725
- pk.medinfo@gsk.com
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where GlaxoSmithKline Pakistan Limited is priced against the market
89 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Amoxil | Amoxicillin | 250 mg | Capsule | 20's | 000213 | PKR 225.83 | PKR 11.29/capsule | 🔒 Pharma Pro |
| Amoxil | Amoxicillin | 250 mg | Capsule | 100's | 000213 | PKR 1,129.16 | PKR 11.29/capsule | 🔒 Pharma Pro |
| Amoxil | Amoxicillin | 250 mg | Capsule | 150's | 000213 | PKR 1,037.30 | PKR 6.92/capsule | 🔒 Pharma Pro |
| Amoxil | Amoxicillin | 125 mg/5 mL | Oral suspension | 90ml | 000508 | PKR 136.66 | PKR 1.52/mL | 🔒 Pharma Pro |
| Amoxil | Amoxicillin | 125 mg/5 mL | Oral suspension | 60ml | 000508 | PKR 91.43 | PKR 1.52/mL | 🔒 Pharma Pro |
| Amoxil | Amoxicillin | 500 mg | Capsule | 20's | 006669 | PKR 407.66 | PKR 20.38/capsule | 🔒 Pharma Pro |
| Amoxil | Amoxicillin | 500 mg | Capsule | 100's | 006669 | PKR 1,995.43 | PKR 19.95/capsule | 🔒 Pharma Pro |
| Amoxil | Amoxicillin | 250 mg/5 mL | Oral suspension | 90ml | 006814 | PKR 202.67 | PKR 2.25/mL | 🔒 Pharma Pro |
| Amoxil | Amoxicillin | 250 mg/5 mL | Oral suspension | 60ml | 006814 | PKR 119.93 | PKR 2.00/mL | 🔒 Pharma Pro |
| Angised | Nitroglycerin | 0.5 mg | Tablet | 100's | 000352 | PKR 213.93 | PKR 2.14/tablet | 🔒 Pharma Pro |
| Angised | Glyceryl Trinitrate | 0.5 mg | Tablet | 60's | 000352 | PKR 128.35 | PKR 2.14/tablet | 🔒 Pharma Pro |
| Angised | Glyceryl Trinitrate | 0.5 mg | Tablet | 30's | 000352 | PKR 66.83 | PKR 2.23/tablet | 🔒 Pharma Pro |
| Augmentin | Amoxicillin + clavulanic acid | 125 mg + 31.25 mg/5 mL | Suspension | 90ml | 009264 | PKR 398.39 | PKR 4.43/mL | 🔒 Pharma Pro |
| Augmentin | Amoxicillin + clavulanic acid | 125 mg + 31.25 mg/5 mL | Suspension | 60ml | 009264 | PKR 196.89 | PKR 3.28/mL | 🔒 Pharma Pro |
| Augmentin | Amoxicillin + clavulanic acid | 125 mg + 31.25 mg/5 mL | Suspension | 75ml | 009264 | PKR 195.83 | PKR 2.61/mL | 🔒 Pharma Pro |
| Augmentin | Amoxicillin + clavulanic acid | 500 mg + 125 mg | Tablet | 6's | 017297 | PKR 301.78 | PKR 50.30/tablet | 🔒 Pharma Pro |
| Augmentin | Amoxicillin + clavulanic acid | 500 mg + 125 mg | Tablet | 10's | 017297 | PKR 460.89 | PKR 46.09/tablet | 🔒 Pharma Pro |
| Augmentin | Amoxicillin + clavulanic acid | 500 mg + 125 mg | Tablet | 12's | 017297 | PKR 591.49 | PKR 49.29/tablet | 🔒 Pharma Pro |
| Augmentin | Amoxicillin + clavulanic acid | 500 mg + 125 mg | Tablet | 15's | 017297 | PKR 678.67 | PKR 45.24/tablet | 🔒 Pharma Pro |
| Augmentin | Amoxicillin + clavulanic acid | 250 mg + 62.50 mg/5 mL | Suspension | 60ml | 018360 | PKR 312.51 | PKR 5.21/mL | 🔒 Pharma Pro |
| Augmentin | Amoxicillin + clavulanic acid | 250 mg + 62.50 mg/5 mL | Suspension | 75ml | 018360 | PKR 302.19 | PKR 4.03/mL | 🔒 Pharma Pro |
| Augmentin | Amoxicillin + clavulanic acid | 250 mg + 62.50 mg/5 mL | Suspension | 90ml | 018360 | PKR 625.38 | PKR 6.95/mL | 🔒 Pharma Pro |
| Augmentin BD TabletRegistry verified | Amoxicillin trihydrate eq. to Amoxicillin, Potassium clavulanate eq. to clavulanic acid | — | — | — | 022244Official source ↗ | No indexed price | — | — |
| Augmentin DS Suspension 312.5mg/5mlRegistry verified | Amoxicillin trihydrate eq to Amoxicillin, Potassium clavulanate eq to clavulanic acid | — | — | — | 018360DOfficial source ↗ | No indexed price | — | — |
| Augmentin Tablets 375mgRegistry verified | Amoxicillin Trihydrate eq. to Amoxicillin , Potassium Clavulanate eq. Clavulanic Acid 125mg | — | — | — | 006747Official source ↗ | No indexed price | — | — |
| Bactroban | Mupirocin | 2% | Ointment | 30g | 010399 | PKR 624.05 | PKR 20.80/g | 🔒 Pharma Pro |
| Bactroban | Mupirocin | 2 % | Ointment | 5g | 010399 | PKR 129.85 | PKR 25.97/g | 🔒 Pharma Pro |
| Bactroban | Mupirocin | 2% | Ointment | 15g | 010399 | PKR 329.47 | PKR 21.96/g | 🔒 Pharma Pro |
| Bactroban | Mupirocin | 2 % | Ointment | 20g | 010399 | PKR 414.66 | PKR 20.73/g | 🔒 Pharma Pro |
| Bactroban | Mupirocin | 2% | Cream | 5g | 028094 | PKR 115.15 | PKR 23.03/g | 🔒 Pharma Pro |
| Bactroban | Mupirocin | 2 % | Cream | 20g | 028094 | PKR 422.97 | PKR 21.15/g | 🔒 Pharma Pro |
| Bactroban | Mupirocin | 2% | Cream | 15g | 028094 | PKR 293.14 | PKR 19.54/g | 🔒 Pharma Pro |
| Bactroban | Mupirocin | 2% | Cream | 30g | 028094 | PKR 636.56 | PKR 21.22/g | 🔒 Pharma Pro |
| Betnovate | Betamethasone valerate | 0.1 % | Lotion | 20ml | 000253 | PKR 125.90 | PKR 6.30/mL | 🔒 Pharma Pro |
| Betnovate | Betamethasone valerate | 0.1% | Lotion | 60ml | 000253 | PKR 359.90 | PKR 6.00/mL | 🔒 Pharma Pro |
| Betnovate | Betamethasone valerate | 0.1% | Cream | 5g | 000256 | PKR 32.33 | PKR 6.47/g | 🔒 Pharma Pro |
| Betnovate | Betamethasone valerate | 0.1% | Cream | 30g | 000256 | PKR 157.36 | PKR 5.25/g | 🔒 Pharma Pro |
| Betnovate | Betamethasone valerate | 0.1 % | Ointment | 5g | 000257 | PKR 32.33 | PKR 6.47/g | 🔒 Pharma Pro |
| Betnovate | Betamethasone | 0.1% | Ointment | 30g | 000257 | PKR 157.36 | PKR 5.25/g | 🔒 Pharma Pro |
| BoostrixSource observed | Diphtheria + Tetanus + Acellular Pertussis vaccine (dTpa) | D ≥2 IU + T ≥20 IU + PT 8 mcg + FHA 8 mcg + pertactin 2.5 mcg/0.5 mL | IM vaccine injection | 1's x 0.5ml | 087954Official source ↗ | No indexed price | — | — |
| Boostrix VaccineSource observed | Diphtheria toxoid + Tetanus toxoid | 2 IU + 20 IU | Vaccine | 1's x 0.5ml | 087954Official source ↗ | No indexed price | — | — |
| Calpol | Paracetamol | 500 mg | Tablet | 500's | 001612 | PKR 1,869.17 | PKR 3.74/tablet | 🔒 Pharma Pro |
| Calpol | Paracetamol | 500 mg | Tablet | 200's | 001612 | PKR 762.93 | PKR 3.81/tablet | 🔒 Pharma Pro |
| Calpol | Paracetamol | 500 mg | Tablet | 400's | 001612 | PKR 1,495.34 | PKR 3.74/tablet | 🔒 Pharma Pro |
| Ceporex | Cephalexin | 125 mg/5 mL | Suspension | 90ml | 003374 | PKR 175.83 | PKR 1.95/mL | 🔒 Pharma Pro |
| Ceporex | Cephalexin | 125 mg/5 mL | Suspension | 60ml | 003374 | PKR 126.16 | PKR 2.10/mL | 🔒 Pharma Pro |
| Ceporex | Cephalexin | 250 mg | Capsule | 18's | 003375 | PKR 316.00 | PKR 17.56/capsule | 🔒 Pharma Pro |
| Ceporex | Cephalexin | 250 mg | Capsule | 12's | 003375 | PKR 210.66 | PKR 17.56/capsule | 🔒 Pharma Pro |
| Ceporex | Cephalexin | 250 mg/5 mL | Suspension | 90ml | 006408 | PKR 316.01 | PKR 3.51/mL | 🔒 Pharma Pro |
| Ceporex | Cephalexin | 250 mg/5 mL | Suspension | 60ml | 006408 | PKR 210.67 | PKR 3.51/mL | 🔒 Pharma Pro |
All 36 GlaxoSmithKline Pakistan brands in Pakistan
- Amoxil Amoxicillin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
- Angised Glyceryl Trinitrate, Nitroglycerin · 0.5 mg tablet
- Augmentin Amoxicillin + clavulanic acid · 125 mg + 31.25 mg/5 mL suspension, 250 mg + 62.50 mg/5 mL suspension, 500 mg + 125 mg tablet
- Bactroban Mupirocin · 2 % cream, 2 % ointment, 2% ointment
- Betnovate Betamethasone valerate, Betamethasone · 0.1 % lotion, 0.1 % ointment, 0.1% cream
- Calpol Paracetamol · 500 mg tablet
- Ceporex Cephalexin · 125 mg/5 mL suspension, 250 mg capsule, 250 mg/5 mL suspension
- Cervarix Human papillomavirus vaccine (bivalent recombinant, HPV 16/18) · HPV16 L1 20 mcg + HPV18 L1 20 mcg / 0.5 mL dose vaccine
- CipVal Ciprofloxacin · 250 mg tablet
- Engerix-B Hepatitis B vaccine (recombinant HBsAg) · 10 mcg/0.5 mL injection, 10 mcg/dose injection, 20 mcg/dose injection
- Fefol Spansule Iron + Folic acid · 250 mg + 0.5 mg capsule
- FixVal Oral Cefixime · 100 mg/5 mL suspension
- Fortum Ceftazidime · 1 g injection, 250 mg injection, 500 mg injection
- Havrix 1440 Hepatitis A vaccine, inactivated · 1440 ELISA units/1 mL dose vaccine
- Havrix 720 Junior Hepatitis A vaccine · 720 ELISA units/0.5 mL vaccine
- Keppra Levetiracetam · 250 mg tablet, 500 mg tablet
- Lamictal Lamotrigine = · 100 mg tablet, 2 mg tablet, 25 mg tablet
- Lanoxin Digoxin · 0.25 mg tablet, 0.5 mg/2 mL injection
- Lotrix Permethrin · 5% cream
- Maxolon Metoclopramide · 10 mg tablet, 10 mg/2 mL injection
- Menveo Meningococcal conjugate vaccine (A, C, Y, W-135) · A 10 mcg + C 5 mcg + W-135 5 mcg + Y 5 mcg / 0.5 mL dose injection
- Rotarix Human rotavirus RIX4414 strain (live, attenuated) · ≥10^6.0 CCID50/dose (1.5 mL) vaccine
- Septran Sulfamethoxazole + Trimethoprim · 80 mg + 400 mg tablet
- Septran DS Sulfamethoxazole + Trimethoprim · 800 mg + 160 mg tablet
- Septran Paediatric Sulfamethoxazole + Trimethoprim · 200 mg + 40 mg / 5 mL suspension
- Silvate Silver Silver sulfadiazine · 1 % cream
- Stiemazol Clotrimazole · 1 % cream
- Synflorix Pneumococcal conjugate vaccine (10-valent) · 1 mcg each (1,5,6B,7F,9V,14,23F) + 3 mcg each (4,18C,19F) vaccine
- Thyroxine Levothyroxine sodium · 50 mcg tablet
- Tivicay Dolutegravir · 50 mg tablet
- Traxon Ceftriaxone · 1 g injection, 250 mg injection
- Ventolin Salbutamol · 0.5 mg/mL injection
- Ventolin Evohaler Salbutamol · 100 mcg inhalation
- Ventolin respirator Salbutamol · 0.5 % solution
- Zinacef Cefuroxime · 1.5 g injection, 250 mg injection, 750 mg injection
- Zyloric Allopurinol · 100 mg tablet, 300 mg tablet
GlaxoSmithKline Pakistan: common questions
How many products does GlaxoSmithKline Pakistan have in Pakistan?
GlaxoSmithKline Pakistan Limited has 104 registered medicine presentations in Pakistan, sold under 36 brands and covering 34 generic medicines.
What are the main brands of GlaxoSmithKline Pakistan?
By number of registered strengths and packs, its largest brands are Augmentin (Amoxicillin + clavulanic acid), Amoxil (Amoxicillin), Bactroban (Mupirocin), Betnovate (Betamethasone valerate, Betamethasone) and Ceporex (Cephalexin). This is not a sales ranking.
Which therapy areas does GlaxoSmithKline Pakistan cover?
The most products are in Anti-infectives (49), Dermatology (14), Vaccines & immunologicals (10), CNS & mental health (9) and Cardiovascular (7).
Where can I see GlaxoSmithKline Pakistan medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.